Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation

CompletedOBSERVATIONAL
Enrollment

817

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

May 31, 2018

Study Completion Date

September 30, 2019

Conditions
Nonvalvular Atrial Fibrillation
Trial Locations (21)

19446

Cardiology Consultants of Philadelphia - Lansdale, Lansdale

20037

Waco Cardiology Associates, Waco

21804

Delmarva Heart LLC, Salisbury

23229

Virginia Cardiovascular Specialists, Richmond

24501

Centra Health, Inc. dba Stroobants Cardiovascular Center, Lynchburg

33173

Heartwell LLP, Miami

33308

Holy Cross Hospital, Inc., Fort Lauderdale

33410

Cardiac Institute of the Palm Beaches, Palm Beach Gardens

33756

Clearwater Cardiovascular & Interventional Consultants MD PA, Clearwater

43606

ProMedica Toledo Hospital, Toledo

48197

Michigan Heart - St. Joseph Mercy Health System, Ann Arbor

49684

Munson Medical Group, Traverse City

60521

Adventist Health Partners, Inc. Amita Health, Hinsdale

75904

The Heart Institute of East Texas, Lufkin

84790

Revere Health-Heart of Dixie Cardiology Central Utah Clinic PC, St. George

92868

Orange County Heart Institute and Research Center, Orange

95508

Alaska Heart Institute, Anchorage

97504

Southern Oregon Cardiology, Medford

98208

Western Washington Medical Group, Inc., Everett

99204

Kootenai Health dba Heart Clinics of the Northwest, Spokane

08844

CardioCare, PC, Hillsborough

All Listed Sponsors
collaborator

American College of Cardiology

OTHER

lead

Baim Institute for Clinical Research

OTHER